FENC logo

FENC

Fennec Pharmaceuticals Inc.

$6.32
$0.00(0.00%)
25
Overall
40
Value
10
Tech
--
Quality
How is this score calculated?
Market Cap
$236.01M
Volume
163.73K
52W Range
$4.68 - $9.92
Target Price
$15.14

Company Overview

Mkt Cap$236.01MPrice$6.32
Volume163.73KChange+0.00%
P/E Ratio--Open$6.37
Revenue--Prev Close$6.32
Net Income--52W Range$4.68 - $9.92
Div YieldN/ATarget$15.14
Overall25Value40
Quality--Technical10

No chart data available

About Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Sector: Healthcare
Industry: Biotechnology

Latest News

Fennec Backs New PEDMARK Study Expanding Cisplatin Ototoxicity Research to Adult Cancers

An update from Fennec Pharmaceuticals ( ($TSE:FRX) ) is now available. Fennec Pharmaceuticals has announced that the University of Arizona Cancer C...

TipRanks Canadian Auto-Generated Newsdeska day ago

Fennec Posts Record PEDMARK Sales in 2025 as Clinical and Commercial Momentum Builds

TipRanks Canadian Auto-Generated Newsdesk12 days ago

Fennec Posts Record PEDMARK Sales in 2025 as Clinical and Commercial Momentum Builds

TipRanks Canadian Auto-Generated Newsdesk12 days ago

Piper Sandler Sticks to Their Buy Rating for Fennec Pharmaceuticals (FENC)

TipRanks Auto-Generated Intelligence Newsdesk14 days ago

Fennec Pharmaceuticals Posts Record PEDMARK Sales and Broadens Clinical Footprint in 2025

TipRanks Canadian Auto-Generated Newsdesk15 days ago
ABCD
1SymbolPriceChangeVol
2FENC$6.320%163.73K
3
4
5
6

Get Fennec Pharmaceuticals Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.